Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment
Professor Federico Cappuzzo gave us an update on the emerging data on the field of lung cancer. There are very important news that were presented during the ESMO, ELCC and EACR. These data are clearly changing the standard of care of patients with early stage Non-Small-Cell Lung Cancer. In this field we have data from two very important trial: the IMpower010 and the KEYNOTE-09.